Motley Fool Asset Management LLC Purchases 10,835 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Motley Fool Asset Management LLC boosted its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 9.7% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 122,592 shares of the company’s stock after acquiring an additional 10,835 shares during the quarter. Motley Fool Asset Management LLC’s holdings in HealthEquity were worth $11,763,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in HQY. Wealthfront Advisers LLC bought a new stake in shares of HealthEquity in the 4th quarter worth approximately $10,304,089,000. Vanguard Group Inc. lifted its stake in HealthEquity by 1.1% in the fourth quarter. Vanguard Group Inc. now owns 8,976,091 shares of the company’s stock worth $861,256,000 after acquiring an additional 99,624 shares during the period. State Street Corp boosted its holdings in HealthEquity by 0.8% in the third quarter. State Street Corp now owns 3,131,900 shares of the company’s stock valued at $256,346,000 after acquiring an additional 23,613 shares in the last quarter. Geode Capital Management LLC increased its position in HealthEquity by 0.5% during the 4th quarter. Geode Capital Management LLC now owns 2,089,398 shares of the company’s stock valued at $200,522,000 after purchasing an additional 10,421 shares during the period. Finally, Franklin Resources Inc. raised its holdings in HealthEquity by 0.7% in the 3rd quarter. Franklin Resources Inc. now owns 1,640,215 shares of the company’s stock worth $139,369,000 after purchasing an additional 11,659 shares in the last quarter. Hedge funds and other institutional investors own 99.55% of the company’s stock.

Insider Activity at HealthEquity

In related news, Director Robert W. Selander sold 5,750 shares of the business’s stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the transaction, the director now directly owns 78,219 shares in the company, valued at $8,704,992.51. The trade was a 6.85 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 2.20% of the stock is currently owned by insiders.

HealthEquity Price Performance

Shares of NASDAQ:HQY opened at $88.74 on Thursday. The business has a fifty day moving average price of $102.66 and a 200-day moving average price of $96.30. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. The company has a market capitalization of $7.68 billion, a PE ratio of 81.41, a PEG ratio of 1.60 and a beta of 0.62. HealthEquity, Inc. has a 1-year low of $65.01 and a 1-year high of $115.59.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on HQY shares. Wells Fargo & Company lifted their target price on shares of HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a research note on Wednesday, February 26th. The Goldman Sachs Group cut their price objective on HealthEquity from $107.00 to $94.00 and set a “neutral” rating on the stock in a research report on Thursday, March 27th. Mizuho started coverage on HealthEquity in a research report on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 target price for the company. KeyCorp lowered their target price on HealthEquity from $120.00 to $110.00 and set an “overweight” rating for the company in a research note on Monday, March 24th. Finally, JMP Securities upped their price target on HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a research note on Tuesday, December 10th. One analyst has rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average price target of $112.58.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.